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Abstract
Background: In 2005, the European Union (EU) started to use a disability-free life expectancy, known as Healthy
Life Years (HLY), to monitor progress in the strategic European policies such as the 2000 Lisbon strategy. HLY are
based on the underlying measure: the Global Activity Limitation Indicator (GALI). Twelve years after its implementation,
this study aims to assess its current use in EU Member States and the European Commission.
Methods: In March 2017, a questionnaire was sent to 28 Member states and the European Commission. The
questionnaire inquired how the GALI and HLY are used to set policy targets, in which surveys the GALI has
been introduced since 2005, how the GALI and HLY are presented, and what the capacity in each country is
to investigate the GALI and HLY.
Results: The survey was answered by 22 Member States and by the Commission. HLY are often used to set
targets and develop strategies in health such as national health plans. Analysis of HLY has even led to policy
change. In some countries, HLY have become the main indicator for health, gaining more importance than
life expectancy. More recently, the GALI and HLY have also been used for policy targets outside the health
sector such as in the area of pension and retirement age or in the context of sustainable development. Regarding
surveys, the GALI is mostly obtained from the EU-SILC, SHARE and EHIS, but is also increasingly introduced in national
surveys. National health reporting systems usually present HLY on their national statistics websites. Most countries have
up to three specialists working on the GALI and HLY, which has been consistent through time. Others have increased
their capacity over various institutions.
Conclusion: HLY is an indicator that is systematically used to monitor health developments in most EU countries. The
SHARE, EU-SILC and EHIS are commonly used to assess HLY through the GALI. The results are then described in reports
and presented on national statistics websites and used in different policy settings. Expertise to analyse the GALI and
HLY is available in most countries.
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Background
Health expectancies combine information on mortality
and morbidity, where the quality of remaining life is as
important as the quantity [1]. Increasingly, health
expectancies are being used as summary measures of
population health, serving as an essential indicator of
the health of the ageing populations [2]. Healthy Life
Years (HLY), a disability-free life expectancy, measures
the expected years lived without participation restriction.
In Europe, it has been monitored since 2005 and was se-
lected to help measure progress in strategic European
policies such as the 2000 Lisbon strategy and the
European strategy on Active and Healthy Ageing [3].
HLY are based on the underlying measure: the Global
Activity Limitation Indicator (GALI) which is provided
through surveys. The question is: “for at least the past
six months, to what extent have you been limited because
of a health problem in activities people usually do?
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Would you say you have been: severely limited? limited
but not severely? not limited at all?”. The development
of the GALI occurred in the framework of the creation
of a coherent set of indicators to monitor health across
Europe [4]. The GALI is one of the three questions of
the Minimal European Health Module (MEHM) which
is a module that was developed to be used in EU social
surveys such as the EU Statistics of Income and Living
Conditions (EU-SILC) and the Eurobarometer [4]. Euro-
stat plays an important role in the coordination of the
EU-SILC and the calculation of HLY.
A HLY improvement is the main health goal of the EU
in order to reduce the social and economic burden with
life expectancy lengthening [5]. The European
Innovation Partnership on Active and Healthy Ageing is
targeting to increase the average HLY of Europeans by
two years by 2020 [3, 6]. Additionally, HLY are used as a
Sustainable Development Indicator (SDI) in the Europe
2020 strategy, being the headline SDI for the public
health theme [7]. The European Commission deployed
efforts to harmonise the instruments and methods used
in EU Member States to measure HLY and has assessed
its uptake in 2006 [8]. They concluded that the use of
the HLY indicator was not (yet) widespread, mainly due
to limited awareness and understanding of the concept.
However, the evaluation only covered the period since
the adoption of HLY as a Lisbon Structural Indicator.
Nonetheless, the evidence showed that the HLY indica-
tor was seen as important to measure progress towards
the Lisbon objectives, in particular because health is a
precursor for economic growth and it is an instrument
to put health capital higher on the European political
agenda [8]. Possible methods to increase the uptake in
policy and actions were identified. This included the im-
provement of dissemination activities by providing easier
access to information and by increasing visibility.
Since 2006, no assessment has been carried out to look
at the use and uptake of the GALI and HLY in the EU.
Despite the EU’s attention, the evolution of the GALI
and HLY indicators has not been examined for over
10 years. This study aims to assess the current use of the
GALI and HLY indicators by the European Commission
and EU Member States. The aim was not to cover a rep-
resentative sample of potential users, but rather to have
a variety of respondents active in the field who could
provide a picture of current uses in Member States and
the EU.
Methods
A questionnaire was sent to experts active in the European
Health and Life Expectancy Information System (EHLEIS)
project, or working in a relevant public health and/or statis-
tical area, in 28 Member states and two departments of the
European Commission [9, 10]. Information was collected
from a sample of 22 public health professionals, active in
the field of health monitoring, belonging to agencies, such
as ministries (n = 2), statistical offices (n = 8), public health
institutes (n = 8) and universities (n = 4) that are potential
users. Two experts from the European Commission
responded to the survey. After purposive sampling, snow-
ball sampling was used. The respondents were asked
whether they were the right contact person to respond to
the survey. If this was not the case, the respondents were
asked to provide contact details for a more suitable contact
person and the survey was forwarded to this person. Out of
the 30 contacted persons, 23 returned their questionnaire,
one suggested other colleagues to be contacted. The ques-
tionnaire was sent by email in March 2017 and a reminder
was sent after one month. One response to the question-
naire per country was aimed for to provide a picture of
current use. Information was complemented with data
available from the EHLEIS network and the literature.
The questionnaire (Additional file 1) was developed
around four topics: policy implications, use in surveys,
dissemination and national capacity in staff. More specif-
ically, the questionnaire inquired if the GALI and HLY
had policy implications and was used to assess the
current situation or set targets in public policy; in
which survey the GALI had been introduced since
2005; how the distribution of the GALI (prevalence of
participation restriction by severity level) and HLY
were presented, discussed and disseminated at na-
tional or regional level; and what the national cap-
acity was to calculate, analyse and follow-up on the
GALI and HLY. The questionnaire consisted of six
open-ended questions which were analysed qualita-
tively by using theme coding and frequency analysis.
Theme coding was used for the analysis of the first
and third topic in which the areas of policy and dis-
semination type were identified and categorised. The
frequency of the use of the different types of surveys
and the number of personnel working on HLY or the
GALI was investigated.
Results
Twenty-two Member States responded to the ques-
tionnaire resulting in a 79% response rate in the
Member States and two responded from the European
Commission. The majority of Member States respon-
dents were part of a public health institute (n = 8) or
a statistical institute (n = 8), but other agencies such as
ministries and universities were also covered with respect-
ively two and four respondents. The non-responding
Member States were Croatia, Ireland, Luxembourg, Malta,
Poland and Portugal. Not all answers addressed the ques-
tions completely, however only 3 out of 144 questions
were left completely unanswered.
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Policy implications
Fifteen countries reported that HLY are used in the pol-
icy domain of health. In these countries, HLY are moni-
tored and used to set targets in national health strategies
or plans. In some cases, the national health plan was
readjusted based on the values of the HLY. In Estonia,
for example, analyses of HLY led to policy change as the
mid-term assessment of the national health plan was not
as good as expected and new plans were set by the
Ministry of Social Affairs. In Italy, results on the indica-
tor trends and their assessment on the impact on pol-
icies is monitored by a high-level committee and
annually presented at the Italian parliament. The impact
on regional policies was difficult to assess as only two
respondents mentioned HLY or the GALI was used at
regional level. The questionnaire revealed, HLY are usu-
ally reported in parallel with LE, however in Lithuania
LE was changed to HLY as the main evaluation criteria
in the program of the government. Furthermore, the
GALI and HLY are used in the public policy area of dis-
abilities and healthy ageing both by Member States and
the European Commission [11, 12], but according to the
respondents, more frequently in the context of sustain-
ability and forecasting which is closely linked to budget
and pension policy areas. Respondents from Belgium,
Czech Republic, Estonia, Hungary, Italy, Lithuania and
Latvia reported HLY to be included in the strategies of sus-
tainable development. Also at the European Commission
within the EU Sustainable Development Strategy, HLY are
a headline indicator [7, 13]. In Estonia, the respondent
stated that it is a government priority to increase HLY in
order to increase people’s years of economic activity, which
in its turn offers the possibility to increase retirement age
and may ensure sustainability of the pension system. In the
Netherlands, the discussion of linking pension age to HLY
was raised, but eventually only LE was taken into account.
In the UK, disability-free life expectancy at age 65 has been
used to inform independent review into the state pension
age. However, Healthy Life Expectancy (HLE), based on
self-perceived health, was used to assess fairness in raising
the state pension.
In the European Commission, HLY and the GALI are
used in various contexts by different Directorate Gen-
erals (DGs) including DG Communication, DG Connect,
DG Employment, DG Eurostat and DG SANTE
(Table 1). HLY are used in the context of the European
Innovation Partnership on Active and Healthy Ageing
and the European Pillar of Social Rights that was
adopted by the European Commission in 2017. HLY at
age 65 was included as a headline indicator on the Social
Scoreboard. DG Eurostat collects the GALI question in
various surveys and HLY for the Sustainable Develop-
ment Indicators (SDI) on public health, the quality of life
indicators on health [7, 14]. The GALI is also gathered
within the context of the European Disability Strategy
2010–2020 of DG Employment [15]. The GALI is used
there to monitor the situation of disabled people to sup-
port the EU’s implementation of the UN Convention on
the Rights of Persons with Disabilities (UNCRPD) [15, 16].
The GALI EU-SILC data is also used by the Academic Net-
work of European Disability Experts (ANED) to produce
estimations of the Europe 2020 indicators on employment
and education in relation to disabled persons. HLY are also
used in the Active Ageing Index by the United Nations
Economic Commission for Europe and the European
Commission [17]. Finally, the European Core Health
Indicator on Health expectancy is also based on HLY
which form the core of the quantitative indicators
used in the Health at a Glance: Europe report, the
Country health profiles, and DG Employment’s Joint
Assessment Framework Health.
The GALI in surveys
All participants reported that the GALI question was in-
troduced in the EU-SILC. Some respondents did point
out the wording had changed over the years since its
introduction. Also in the European Health Interview
Survey (EHIS) most countries have the GALI question
included. Only Austria reported it had removed the
GALI question from the EHIS. Eight countries indicated
to have the GALI question in other national or regional
surveys. Only two countries mentioned to have the
GALI question in the Survey of Health, Ageing and
Retirement in Europe (SHARE) in their country, even
though the SHARE containing the GALI question is
currently carried out in 16 EU Member States. Other
Surveys mentioned by participants were the censuses
(N = 2), the European health examination survey (N = 2),
and various other surveys on health status, health care,
living style, work, school health, housing, family re-
sources, life opportunities, gender and social protection.
In Belgium, the GALI is even used in small scale studies
e.g. on Lyme disease. Negotiations between Eurostat and
the EU Member States are ongoing to insert the GALI
as a disability variable into the Labour Force Survey
once every two years, thus creating a reliable monitoring
tool on the employment of people with disabilities. The
2017 SILC module on children also includes a disability
perspective (the GALI variable adapted for children),
thus bridging the knowledge gap regarding children with
disabilities in households.
Presentation and dissemination of HLY
Country reports are yearly produced by EHLEIS [18]. In
the country reports, Member States have since 2014 the
opportunity to add a one-page summary of research
done within their country. This page was filled in on
average by 12 of the 28 EU countries between 2014 and
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2016. The country reports also contain a yearly update
of a bibliography of reports and scientific papers on the
GALI and HLY published within the country. Eight
countries reported to have published the country reports
on national websites of statistics, social affairs or of their
presidency. HLY are also presented in other national re-
ports on the state of the health of the population,
well-being and pension. In France, HLY are reported in a
major national plan, being the Report on New Indicators
of Wealth [19]. Since HLY are measured through the
GALI question in the EU-SILC or the EHIS, reports on
the surveys often also mention HLY. Data on HLY are
most often published on the national statistics website
(n = 11). In the Czech Republic, a special page is
even allocated to HLY on the website of the Institute
of Health Information and Statistics [20]. In the UK,
this is a page on comparisons and inequalities in
healthy life expectancies (HLE), disability-free life ex-
pectancies (DFLE) and life expectancies (LE). The
European Commission has a Eurostat metadata page
allocated to HLY and reports on HLY on various
other websites and in reports [14]. Also in Belgium,
HLY data are presented on the website with standar-
dised procedures for mortality analysis (SPMA) and
on the website of the Belgian HIS. The latter is an
interactive website where the GALI and HLY esti-
mates are available by region [21]. Finally, several
EU research groups work on HLY estimations and
use it in research on health inequality, health prior-
ity setting and impact of life styles. In Lithuania for
example, the university of health sciences publishes
findings on HLY.
Capacity working on the GALI or HLY
One of the main tasks of the EHLEIS project was to in-
crease the capacity to analyse HLY within the EU
through training workshops and guidelines for estima-
tion and interpretation of HLY [8]. The EHLEIS project
created a domain specific network which is currently ac-
tive in all EU member states. Most countries reported to
have three to four people working on the GALI and
HLY. The capacity is usually distributed between the na-
tional public health institutes, the statistics offices and
universities. The people involved also analyse data and
calculate indicators for the EU-SILC and EHIS. HLY and
the GALI are only a small part of their daily work. Three
countries mentioned the capacity had increased over the
years i.e. Slovenia, Czech Republic and Estonia. Four
countries reported the capacity had remained unchanged
i.e. Denmark, Cyprus, Greece and Lithuania. Estonia and
Latvia had the highest capacity, even though the GALI
and HLY are a small part among other tasks in these in-
stitutions. The Réseau Espérance de Vie en Santé
(REVES) directory further informs on the research
groups active in the field spread over 13 EU countries
[22]. In the European Commission, there is one person
involved in production of data and one person involved
in methodology and dissemination, but also here the ac-
tivities compose only a very small share in their total
work assignments. The capacity in the European Commis-
sion is within Eurostat and is rather low at the moment.
The capacity was higher during the EHLEIS project or
when the Task Force on GALI was active or when specific
projects related to the GALI or HLY were running. In
general, the respondent from the Commission stated that
Table 1 Overview of the use of Healthy Life Years in the European Commission (2005–2017)
Directorate General Use of Healthy Life Years Measurement
DG Communication Eurobarometer. Prevalence of activity limitation
through survey instrument: GALI question.
Self-reported limitations in daily activities by age,
sex and income level (SI-C11)
DG Eurostat Metadata sheet healthy life years Healthy Life Years at birth, at 50, at 65 and by sex
Sustainable Development Indicator Healthy life years and life expectancy at birth, by sex
Quality of Life indicators on health Healthy Life Years at birth, at 65, by sex
DG Connect and wider
European Commission
European Innovation Partnership on Active
and Healthy Ageing: target 2020
Healthy life years at birth, by sex
DG Employment Social Protection & Social Inclusion Healthy Life Years at birth, at 65, by sex (SI-C4a)
Self-reported limitations in daily activities by age,
sex and income level (SI-C11)
European Pillar of Social Rights on Social Scoreboard Healthy life years at the age of 65, by sex
Joint Assessment Framework (JAF on health) Healthy Life Years at birth, at 65, by sex (H-2)
European Disability Strategy (2010–2020). Prevalence
of activity limitation through survey instrument:
GALI question.
Self-reported limitations in daily activities by age,
sex and income level
DG Sante Health at a Glance: Europe report, Country health profiles European Core Health Indicators on long-term activity
limitations by sex, age and educational level (ECHI 35)
European Core Health Indicators on Health expectancy:
Healthy Life Years at birth, at 65, by sex (ECHI 40)
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there are less resources dedicated to the GALI or HLY at
the moment as the production and dissemination follows
already established procedures. However, some develop-
ment projects are envisaged.
Discussion
The GALI and HLY are important measures to monitor
progress in various policy domains. Since the last evalu-
ation in 2006 [8], the use of the HLY indicator has
spread and gained attention and the respondents to our
survey reported different uses. Analysis of the HLY have
led to policy changes in e.g. Estonia and are discussed in
high level political meetings in countries such as France
and Italy, and at the European Commission, most re-
cently, in the context of the European Pillar of Social
Rights where HLY are a headline indicator. In Lithuania,
HLY have even taken over LE as the main evaluation cri-
teria in the program of the government. In contrast with
2006, HLY are now being used to design policies and
programmes. The most widespread use of the GALI and
HLY are in the area of health, but since health is ac-
knowledged as a precursor of economic growth and im-
portant for economic decisions, HLY have gained
importance in other policy areas as well. HLY and the
GALI are used in at least 5 different Directorate Gen-
erals (DGs) of the Commission, including its use in the
European Semester. In contrast with the report of
Oortwijn et al. [8], Commission Officials do seem to be
aware of the HLY indicator as its use has spread. The re-
sults from the survey show that HLY are frequently used
in the context of sustainability, where HLY are reported
and monitored in the strategies of sustainable develop-
ment of many countries and at the European Commis-
sion. This because HLY have gained major importance
in discussions on retirement age and pension. In some
countries such as Estonia, it is a policy priority to in-
crease HLY in order to increase people’s years of eco-
nomic activity. The efforts of the European Innovation
Partnership on Active and Healthy Aging, the Task Force
on GALI and the EHLEIS project may have contributed
to countries endeavours to increase HLY. Also in the
policy domain of disabilities, HLY have gained political
importance. Not all countries have taken up HLY sys-
tematically. In the Netherlands, for example, only LE is
taken into account for pension age. Methodological is-
sues and fluctuations are other important reasons for its
limited use in e.g. Slovenia. At regional level, most re-
cently, the Flemish region in Belgium has used healthy
life years in their proposal to address social inequalities
in health and wellbeing [23]. However, the policy impli-
cations at regional level seem rather limited according to
the survey. This should be investigated in more depth to
make any conclusive remarks as regional policy-makers
were not specifically targeted in this study.
The GALI question is institutionalised in most import-
ant health questionnaires through the MEHM such as
the EU-SILC, the SHARE and the EHIS [24]. This was
initiated by Eurostat to have a health benchmark in all
their major surveys including the non-health surveys.
Interestingly, in our study, only few countries were
aware the GALI was questioned through the SHARE in
their country. Overall, the biggest limitation is that sur-
vey organisers use their own adaptation of the question.
This leads to a variety of wording in different surveys
and may limit comparability [25]. Eurostat and EHLEIS
have provided support to countries with regards to har-
monisation, but continuous efforts will be needed in
order for the GALI question not to be altered or re-
moved. Since the capacity has decreased in the European
Commission, and the Task Force on GALI and the
EHLEIS project have come to an end, it would be inter-
esting to look at the impact of these changes on the use
of the GALI and HLY in the future. In this survey, only
one country reported to have removed the GALI ques-
tion from the EHIS. Respondents to the survey also indi-
cated the GALI question is used in various other
surveys. Also at regional level and in smaller scale stud-
ies, the GALI has been introduced.
HLY are presented in various reports. The country re-
ports produced by EHLEIS are well received by coun-
tries and increase the uptake of HLY at national level as
the reports are published on countries websites. This is
important to improve the understanding of the concept
in a unified way and to provide a yearly update. Further-
more, the presentation and dissemination of HLY are
most prominent on national statistics websites. Some
countries provide data analysis and conclusions on their
HLY results increasing the visibility of the GALI and
HLY. Other findings on HLY are presented in reports on
the EU-SILC and EHIS. The capacity working on the
GALI and HLY in the Member States has either
remained unchanged or slightly increased over the years.
The capacity is usually spread over various institutions
being national public health institutes, statistics offices
and universities.
At the European Commission, HLY are reported in
various health reports such as the Country health pro-
files and in Health at a glance: Europe report. Also out-
side the health domain, HLY are used in reports on
social protection and inclusion as well as on disability
and employment. The production and dissemination of
HLY and the GALI follow already established procedures
which confirm their institutionalisation, but has a de-
cline in resources and capacity at EU – level as a
consequence.
Since only one respondent per country was aimed for
in this study, due to resources constraints, the responses
may have been incomplete and may not reflect a country
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wide perspective. Also, the results from the study dem-
onstrated that the areas in which the GALI and HLY are
used can be broad and the respondents may only be
aware of use in certain areas. However, the respondents
were chosen due to their active participation in the
EHLEIS network and their expertise in the field. There-
fore, they seemed to be suitable to respond to the ques-
tionnaire. Participants were also asked to provide
another contact person if they did not know the answers
to the questionnaire. Various respondents provided links
to national reports and websites. Due to the language
barrier not all reports could be assessed thoroughly.
Conclusion
In ten years, there has been a real evolution in the use
of the GALI and HLY. The use of the GALI and HLY
are now widespread in Member States and in the Euro-
pean Commission and has, over the years, become insti-
tutionalised. The GALI and HLY are used for policy
making (e.g. health promotion and functional capacity of
the work force), impact assessment (e.g. impact of
healthy life style on health), and monitoring (e.g. trends
in social protection). Additionally, HLY are increasingly
being used to design policies and programmes. The
GALI and HLY are not only used in the policy area of
the health sector encompassing disabilities and healthy
ageing, but have also gained importance in other fields
such as retirement, budgets and sustainable develop-
ment. The GALI is integrated in major health surveys
which support its long-term sustainability. Although the
capacity fluctuates between countries, most countries
have capacity to evaluate the GALI and HLY. This ana-
lysis encourages further documenting for the policy
makers how HLY and the GALI are measured and what
type of interpretation can be driven from the secular or
cross-country comparisons.
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